# A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease

> **NCT00540670** · PHASE2 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 240 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** E5555 50 mg
- **DRUG:** E5555 100 mg
- **DRUG:** E5555 200 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00540670
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-03
- **Final completion:** —
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2013-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540670, "A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00540670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*